Shinoura N, Nishijima M, Hara T, et al. Brain tumors: detection with 11C-choline PET[J]. Radiology, 1997, 202: 497-503.
[2]
de Winter F, Van de Wiele C, Dumont F, et al. Biodistribution and dosimetry of 99m-Tc-ciprofloxacin, a promising agents for diagnosis of bacterial infection[J]. Eur J Nucl Med, 2001, 28: 570-574.
[3]
Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using 11C-choline[J]. J Nucl Med, 1998, 39: 990-995.
[4]
Britton KE, Vinjamuri S, Hall AV, et al. Imaging bacterial infection with (99m)Tc- ciprofloxacin (Infecton) [J]. J Clin Pathol, 2002, 55: 817-823.
[5]
Dumarey N, Blocklet D, Appelboom T, et al. Infecton is not specific for bacterial osteoarticular infective pathology[J]. Eur J Nucl Med, 2002, 29: 530-535.
[6]
Sarda L, Cremieux AC, Lebellec Y, et al. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular disease[J]. J Nucl Med, 2003, 44: 920-926.
[7]
Siaens RH, Rennen HJ, Boerman OC, et al. Synthesis and evaluation of 99mTc-enrofloxacin, 99mTc-ciprofloxacin[J]. J Nucl Med, 2004, 45: 2 088-2 094.
[8]
Zhang H, Tian M, Oriuchi N, et al. 11C2-choline PET for the detection of bone and soft tissue tumors in comparison with FDG PET[J]. Nucl Med Commun, 2003, 24: 273-279.
Zijlstra S, Gunawan J, Freytag C, et al. Synthesis and evaluation of fluorine18 labeled compounds for imaging of bacterial infections with PET[J]. Appl Radiat Isot, 2006, 64: 802-807.
[11]
Langer O, Brunner M, Zeitlinger M, et al. In vitro and in vivo evaluation of [(18)F]-ciprofloxacin for imaging of bacterial infections with PET[J]. Eur J Nucl Med Mol Imaging, 2005, 32: 143-150.
[12]
Procaccini E, Chianelli M, Pantano P, et al. Imaging of autoimmune disease[J]. Q J Nucl Med, 1999, 43: 100-112.
[13]
Signore A, Chianelli M, Annovazi A, et al. 123I-interleukin-2 scintigraphy for in vivo assessment of interstitial mononuclear cell infiltration in Crohn’s disease[J]. J Nucl Med, 2000, 41: 242-249.
[14]
Rennen HJ, Bleeker-rovers CP, van Eerd JE, et al. 99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections[J]. Chest, 2004, 126: 1 954-1 961.
[15]
Bleeker-rovers CP, Rennen HJ, Boerman OC, et al. 99mTc-labeled interleukin8 for scintigraphic detection of infection and inflammation: first clinical evaluation[J]. J Nucl Med, 2007, 48: 337-343.
[16]
van Eerd JE, Boerman OC, Corstens FH, et al. Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation[J]. Q J Nucl Med, 2003, 47: 246-255.
[17]
van Eerd JE, Broekema M, Harris TD, et al. Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist[J]. J Nucl Med, 2004, 45: 1 747-1 753.
[18]
Diksic Y, Yamamoto L, Feindel W. Synthesis of 11C-labeled choline[J]. J Labelled Comp Radiopharm, 1984, 14: 9-15.
[19]
van Eerd JE, Broekema M, Harris TD, et al. Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist[J]. J Nucl Med, 2005, 46: 1 546-1 551.
[20]
Pascali C, Bogni A, Iwata R, et al. 11C-methylation on a C18 Sep-Pakcartridge: a convenient way to produce N-methyl-11C-choline[J]. J Labelled Comp Radiopharm, 2000, 43: 195203.
